blend labs inc - BLND

BLND

Close Chg Chg %
3.17 0.12 3.79%

Closed Market

3.29

+0.12 (3.79%)

Volume: 2.90M

Last Updated:

Jan 9, 2026, 3:59 PM EDT

Company Overview: blend labs inc - BLND

BLND Key Data

Open

$3.32

Day Range

3.28 - 3.44

52 Week Range

2.50 - 4.49

Market Cap

$810.41M

Shares Outstanding

259.75M

Public Float

191.15M

Beta

1.24

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.10

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.95M

 

BLND Performance

1 Week
 
8.94%
 
1 Month
 
5.11%
 
3 Months
 
3.79%
 
1 Year
 
-2.08%
 
5 Years
 
N/A
 

BLND Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About blend labs inc - BLND

Blend Labs, Inc. is a digital origination platform serving banks, credit unions, and mortgage lenders. It operates through the Blend Platform and Title segments. The Blend Platform segment consists of a suite of products that power the entire origination process from back-end workflows to consumer experience. The Title segment includes a suite of title products and services, such as instant title and other title search options, insurance solutions, closing and settlement services, including mobile signing and e-sign capabilities, and various post-closing solutions, such as disbursement and recording handling. The company was founded by Nima Ghamsari, Rosco Hill, Eugene Marinelli, and Erin James Collard on April 17, 2012 and is headquartered in Novato, CA.

BLND At a Glance

Blend Labs, Inc.
7250 Redwood Boulevard
Novato, California 94945
Phone 1-650-550-4810 Revenue 162.02M
Industry Packaged Software Net Income -60,483,000.00
Sector Technology Services 2024 Sales Growth 3.298%
Fiscal Year-end 12 / 2025 Employees 540
View SEC Filings

BLND Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 6.598
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -32.083
Enterprise Value to Sales 7.181
Total Debt to Enterprise Value 0.125

BLND Efficiency

Revenue/Employee 300,035.185
Income Per Employee -112,005.556
Receivables Turnover 8.14
Total Asset Turnover 0.844

BLND Liquidity

Current Ratio 3.438
Quick Ratio 3.438
Cash Ratio 2.657

BLND Profitability

Gross Margin 55.226
Operating Margin -26.015
Pretax Margin -26.731
Net Margin -37.331
Return on Assets -31.495
Return on Equity N/A
Return on Total Capital -67.852
Return on Invested Capital -57.011

BLND Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 163.223
Total Debt to Total Assets 81.733
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 159.822
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Blend Labs Inc - BLND

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
234.50M 235.20M 156.85M 162.02M
Sales Growth
+144.19% +0.30% -33.31% +3.30%
Cost of Goods Sold (COGS) incl D&A
126.64M 153.96M 75.71M 72.54M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
13.81M 14.42M 5.76M 5.89M
Depreciation
4.61M 5.95M 5.70M 4.33M
Amortization of Intangibles
9.21M 8.47M 64.00K 489.00K
COGS Growth
+269.34% +21.57% -50.82% -4.18%
Gross Income
107.85M 81.24M 81.14M 89.48M
Gross Income Growth
+74.69% -24.68% -0.13% +10.28%
Gross Profit Margin
+45.99% +34.54% +51.73% +55.23%
2021 2022 2023 2024 5-year trend
SG&A Expense
296.60M 362.46M 212.41M 131.63M
Research & Development
92.22M 138.09M 81.59M 46.09M
Other SG&A
204.38M 224.37M 130.82M 85.54M
SGA Growth
+116.44% +22.21% -41.40% -38.03%
Other Operating Expense
- - - -
-
Unusual Expense
8.50M 464.95M 24.95M 3.73M
EBIT after Unusual Expense
(197.24M) (746.18M) (156.22M) (45.88M)
Non Operating Income/Expense
493.00K 4.92M 7.25M 9.32M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
11.28M 24.79M 30.81M 6.75M
Interest Expense Growth
- +119.79% +24.29% -78.10%
Gross Interest Expense
11.28M 24.79M 30.81M 6.75M
Interest Capitalized
- - - -
-
Pretax Income
(208.03M) (766.05M) (179.78M) (43.31M)
Pretax Income Growth
-178.89% -268.24% +76.53% +75.91%
Pretax Margin
-88.71% -325.70% -114.63% -26.73%
Income Tax
(38.89M) (2.24M) 94.00K 109.00K
Income Tax - Current - Domestic
425.00K 355.00K 41.00K 64.00K
Income Tax - Current - Foreign
- 268.00K 87.00K 11.00K
Income Tax - Deferred - Domestic
- - (39.31M) (2.86M)
-
Income Tax - Deferred - Foreign
- - (34.00K) 34.00K
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(1.43M) (48.44M) (6.63M) (17.14M)
Consolidated Net Income
(170.57M) (812.25M) (186.51M) (60.56M)
Minority Interest Expense
771.00K (43.64M) (1.19M) (74.00K)
Net Income
(171.34M) (768.61M) (185.32M) (60.48M)
Net Income Growth
-129.63% -348.58% +75.89% +67.36%
Net Margin Growth
-73.07% -326.79% -118.15% -37.33%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(171.34M) (768.61M) (185.32M) (60.48M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(171.34M) (768.61M) (185.32M) (60.48M)
EPS (Basic)
-0.7439 -3.2824 -0.7558 -0.2382
EPS (Basic) Growth
-118.92% -341.24% +76.97% +68.48%
Basic Shares Outstanding
230.32M 234.16M 245.21M 253.92M
EPS (Diluted)
-0.7439 -3.2824 -0.7558 -0.2382
EPS (Diluted) Growth
-118.92% -341.24% +76.97% +68.48%
Diluted Shares Outstanding
230.32M 234.16M 245.21M 253.92M
EBITDA
(174.93M) (266.81M) (125.51M) (36.26M)
EBITDA Growth
-153.72% -52.52% +52.96% +71.11%
EBITDA Margin
-74.60% -113.44% -80.02% -22.38%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 4.85
Number of Ratings 7 Current Quarters Estimate 0.009
FY Report Date 03 / 2026 Current Year's Estimate 0.079
Last Quarter’s Earnings 0.01 Median PE on CY Estimate N/A
Year Ago Earnings 0.02 Next Fiscal Year Estimate 0.144
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 6 5
Mean Estimate 0.01 0.02 0.08 0.14
High Estimates 0.02 0.04 0.12 0.17
Low Estimate -0.01 0.01 0.02 0.09
Coefficient of Variance 178.60 61.36 54.84 22.62

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Blend Labs Inc - BLND

Date Name Shares Transaction Value
Sep 10, 2025 Eric H. Woersching Director 30,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $4 per share 120,000.00
Sep 10, 2025 Oxana Tkach PRINCIPAL ACCOUNTING OFFICER 52,780 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $4 per share 211,120.00
Aug 13, 2025 Winnie Ling HEAD OF LEGAL AND PEOPLE 372,018 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.62 per share 1,346,705.16
Jul 18, 2025 Brian Kneafsey Head of Revenue 721,598 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.63 per share 2,619,400.74
Jul 18, 2025 Eric H. Woersching Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 18, 2025 Eric H. Woersching Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 18, 2025 Brian Kneafsey Head of Revenue 746,598 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.42 per share 2,553,365.16
Jul 17, 2025 Timothy J. Mayopoulos Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Erin N. Lantz Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Erin N. Lantz Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Erin N. Lantz Director 87,760 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Gerald C. Chen Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Gerald C. Chen Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Gerald C. Chen Director 87,760 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Bryan E. Sullivan Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Bryan E. Sullivan Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Bryan E. Sullivan Director 50,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Timothy J. Mayopoulos Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Timothy J. Mayopoulos Director 381,130 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Nima Ghamsari HEAD OF BLEND; Director 4,200,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Blend Labs Inc in the News